AlzeCure Pharma: “We have good momentum”
AlzeCure Pharma, which develops small molecule drugs for the treatment of Alzheimer's disease and pain, is currently in the process of a rights issue...
BioStock Investor Pitch: AlzeCure Pharma
Swedish AlzeCure Pharma develops small molecule drug candidates for the treatment of...
BioStock Investor Pitch: Klaria Pharma
Swedish Klaria Pharma is active in migraine and...
Klaria Pharma: "We have a good product in a large market"
Klaria Pharma has taken the step from being...
Alzinova is pursuing partnerships at BIO
The largest biotechnology conference of the year is currently taking place...
RECOMMENDED
Report commentary, company presentation or capital markets day?
Communicate professionally with the market and nurture your brand!
BioStock's studio meets your needs with technical quality and expertise.
Aqilion: "It has been a really busy year"
Summer is upon us and it's time to...
BioStock Investor Pitch: Chosa Oncology
Biotechnology company Chosa Oncology focuses on precision medicine in cancer treatment....
A visionary outlook on cancer therapy for 2040
This panel on the future of immunooncology has...
Abarceo Pharma | Global Forum 2025
Chairman and CEO Adam Bruce presents Abarceo Pharma...
IRLAB Therapeutics | Global Forum 2025
CEO Kristina Torfgård presents IRLAB Therapeutics at BioStock...
Alligator BioScience | Global Forum 2025
CEO Søren Bregenholt presents Alligator BioScience at BioStock...
Fireside Chat with Steve Smith and Søren Bregenholt
An in-depth conversation of IP and its procedures...
Health & Wealth #19 | Live with Martin Åmark, Xbrane Biopharma | Global Forum 2025
A Health & Wealth podcast episode featuring Martin...
Xbrane Biopharm | Global Forum 2025
CEO Martin Åmark presents Xbrane Biopharma at BioStock...
BioInvent International | Global Forum 2025
CSO Björn Frendéus presents BioInvent International at BioStock...
Simsen Diagnostics | Global Forum 2025
CEO Pontus Rhen presents Simsen Diagnostics at BioStock...
Smart Money in Life Science – Insights from Top Investors
A Panel discussion at BioStock Global Forum featuring...
Notes
Cantargia publishes data for nadunolimab in lung cancer
Genmab reports sales of DARZALEX
AlzeCure receives additional subscription commitments of SEK 7 million
AstraZeneca updates on phase III study
Orexo maintains full-year forecast despite currency headwinds
NEWSLETTER
NEWS
Biovica's blood test provides new answers for cancer care
Green light for PHI to step up its commercial strategy
Enzymatica's CEO comments on his resignation
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
The market is taking Trump's tariff threat in stride
The EU's new life science strategy – a step in the right direction or just fluff?
